Medtronic Kanghui Debuts Localized AiBLE™ Digital Innovation Ecosystem at CIIE, Unveiling Three Made-in-China Smart Medical Devices

The 7th China International Import Expo (hereinafter referred to as "CIIE") was grandly held in Shanghai. As a regular participant of CIIE, Medtronic arrived as scheduled this year with a series of significant intelligent products made in China. The debut highlights included Medtronic's first locally manufactured spinal surgery navigation and positioning system, Mazor™ XC, Kanghui Medtronic’s first domestically produced spinal surgery navigation system, EngineNav™ QíngHáng™, and Medtronic's first neurophysiological monitoring system manufactured in China, NIM-ECLIPSE™. Among them, Mazor™ XC was selected as an outstanding achievement of local innovation for display at the "Invest in China" exhibition area in the China Pavilion. Meanwhile, Kanghui Medtronic also showcased several key practice achievements in the development of new quality productivity, covering the local “quality” smart innovation ecosystem, clinical research plans targeting digital intelligence technology, and the overseas initiatives of products made in China. With multi-dimensional digital intelligence innovation, these efforts aim to boost the development of new quality medical productivity.

"CIIE is held annually, and every year brings a new role. This year, CIIE has advanced to become an important platform for fostering and developing new quality productive forces, while Medtronic Kanghui has transformed from an exhibitor introducing advanced technologies into an investor and participant in local innovation. As we attended CIIE again this year, we not only showcased leading product technologies but also comprehensively demonstrated our achievements in driving industry-wide upgrades and promoting the development of new medical productivity through digital intelligence innovation." said Yu Jing, Vice President of Medtronic and General Manager of China Orthopedics, Neurosurgery, and Surgical Business. "Building on the industrialization, clinical value transformation, and globalization of the AiBLET™ digital intelligence ecosystem, we hope to leverage the power of digital intelligence innovation to create new momentum, new value, and new directions for the development of new medical productivity."

The CIIE has always been a high-quality platform full of vitality and innovation. Over the years, Medtronic Kanghui has continuously brought globally cutting-edge innovative technologies, products, and solutions to China. Benefiting from the "spillover effects" of the CIIE, it has accelerated the promotion of many innovative achievements, represented by the star product MazorX™ Spine Surgery Robot, realizing the transformation from "exhibits" to "commodities" and from "global goodies" to "locally manufactured in China."

At this year's CIIE, Medtronic Kanghui unveiled three innovative locally-produced intelligent devices: the Mazor™ XC Spine Surgery Navigation and Positioning System, the EngineNav™ Spine Surgery Navigation System, and the NIM-ECLIPSE™ Neurophysiological Monitoring System. With a more diverse range of localized products, these innovations drive the localization of the AiBLE™ digital ecosystem, providing Chinese doctors and patients with diversified high-quality medical solutions. Notably, the Mazor™ XC has been developed and upgraded based on the imported Mazor X™ platform to better meet the needs and surgical habits of Chinese clinical practices, offering enhanced adaptability and compatibility. It received the domestically produced medical device registration certificate from the National Medical Products Administration on October 28 this year.

Mr. Cao Hongying, Standing Vice President of the China Association of Enterprises with Foreign Investment, Mr. Hang Hongwei, Deputy Director of the Changzhou National High-tech Industrial Development Zone Management Committee and Deputy District Chief of Xinbei District People's Government, Mr. Gu Yushao, Senior Vice President of Medtronic Global and President of Medtronic Greater China, Ms. Yu Jing, Vice President of Medtronic, General Manager of China Orthopedics, Neurosurgery and Surgical Business, along with other leaders from Medtronic Greater China, jointly unveiled three locally manufactured smart devices and the local AiBLE™ Innovation Ecosystem.

 Launch Ceremony of Three Local Innovative Products: The Debut of the Local AiBLE™ Digital Intelligence Innovation Ecosystem

The above three locally innovative products are all from the Medtronic Kanghui Changzhou Science and Technology Park, jointly developed by Medtronic Kanghui and the Changzhou National High-Tech Zone. In the future, leveraging the park's comprehensive localization capabilities and industrial chain layout, Medtronic Kanghui will successively achieve the localized research, production, and innovation of a series of intelligent devices, including intraoperative navigation, intracranial pressure monitoring systems, and intraoperative neuromonitoring systems. This will form a full range of localized AiBLE™ digital and intelligent orthopedic and neurosurgery innovative ecosystem products. The industrialization of the AiBLE™ digital and intelligent ecosystem will drive local industries to achieve chain innovation and boost their digital and intelligent transformation and upgrading. Meanwhile, relying on the park’s four key functions — the Clinical Customer Center, Intelligent Manufacturing Center, Excellence R&D Center, and Innovation Incubation Center — Medtronic Kanghui will further expand and deepen industry-university-research-clinical collaborations. It will also accelerate the validation and incubation of innovative products, achieving clinical implementation and industrialization, continuously providing new momentum for the development of new quality productive forces through ongoing innovation.

At the 6th CIIE, Medtronic, as an innovative leader in the medical technology field, took the lead in launching the "AiBLE™ Digital Intelligence Innovation Ecosystem," guiding the industry into a new era of digital intelligence powered by big data connectivity and AI. Over the past year, this ecosystem has achieved multiple clinical implementations, promoting the practical application of digital intelligence technology in Chinese clinics, empowering clinicians to effectively utilize "new quality technologies," and nurturing more "new quality talents." This, in turn, helps improve clinical outcomes and healthcare efficiency, providing patients with "new quality services."

To better support local medical decision-making in China and further accelerate the implementation of the AiBLE™ digital intelligence ecosystem's value, Medtronic Kanghui officially announced the AiBLE™ Digital Orthopedics Clinical Research Project plan at the CIIE with several leading hospitals. The project will focus on the characteristics of Chinese patients, using multi-center, segmented, prospective real-world data randomized controlled trials to demonstrate the multidimensional value of the digital orthopedics innovation ecosystem in clinical, economic, and patient aspects. It aims to enhance the development of high-quality intelligent spine surgery and boost academic influence, promoting the advancement of spinal surgery into the digital, intelligent, and minimally invasive era.

AiBLE™ Intelligent Orthopedics Innovation Ecosystem Clinical Research Program Launch Ceremony

Professor Ma Xiaosheng, Director of the Department of Orthopedics at Huashan Hospital Affiliated to Fudan University, Professor Lian Xiaofeng, Director of the Department of Spinal Surgery at Shanghai Sixth People's Hospital, and Professor Wu Wenjian, Deputy Chief Physician of the Department of Orthopedics at Shanghai Ruijin Hospital, participated in this event and jointly released the AiBLE™ Intelligent Orthopedics Innovation Ecosystem Clinical Research Program Project with the leadership of Medtronic Greater China.

Professor Ma Xiaosheng, Director of the Orthopedics Department at Huashan Hospital Affiliated with Fudan University, stated, "As an important component of medicine, orthopedics is also actively exploring and attempting to integrate artificial intelligence technology into clinical practice, with the aim of improving diagnostic and treatment efficiency, optimizing treatment plans, and ultimately enhancing patient satisfaction and recovery quality. Participating in this significant research project will help us collaborate with all parties to promote innovative development in orthopedic medicine, and it will also assist clinicians in bringing new treatment experiences and recovery hopes to patients. At the same time, we look forward to the application of AiBLE™ Digital Intelligence Orthopedic Technology in clinical practice, using precise, efficient, and personalized solutions to increase patient benefits."

As a core platform for gathering global new-quality resources, the CIIE is also an open window to enhance the linkage effect of resources in both domestic and international markets, connect with new-quality productivity, and jointly explore opportunities in China. Leveraging the powerful magnetic effect of the CIIE, Medtronic Kanghui further upgraded its "circle of friends" at this year’s CIIE. It signed a strategic cooperation agreement with overseas distributors represented by Macromed (Pty) Ltd. regarding the "going-out" strategy for locally manufactured representative products. This will promote the AiBLE™ innovative solution globally, enhance the influence of Chinese manufacturing, and benefit a broader range of patients.

Macromed (Pty) Ltd., a South African company specializing in orthopedic medical devices, stated through its General Manager Michael Poxon that their renewed partnership with Medtronic Kanghui today is driven by the profound realization that "Made in China" has evolved into "Quality Made in China," which represents the momentum of Chinese innovation. This transformation brings vibrant opportunities and support for our company’s development. We also look forward to achieving more fruitful cooperation on the open platform of the CIIE in the future.

 Medtronic Kanghui-Macromed Cooperation Signing Ceremony

Currently, the business of Medtronic Kanghui has covered 65 countries and regions worldwide. In the future, Medtronic Kanghui will collaborate with more overseas distributors and global partners, using policies such as the "Belt and Road" as a bridge to make "Made in China" go further. Upholding an open and cooperative mindset, it will work with a broader range of Chinese and foreign partners to explore new paths for the development of new quality productive forces, share the dividends of the development of new quality productive forces with global partners, and achieve a win-win future.